[go: up one dir, main page]

EE200300530A - EF-Tu proteiiniga seostuvate ainete kasutamine antibakteriaalse vahendi valmistamiseks, sel viisil saadud antibakteerikum ning meetod uute bakterivastaste toimeainete identifitseerimiseks - Google Patents

EF-Tu proteiiniga seostuvate ainete kasutamine antibakteriaalse vahendi valmistamiseks, sel viisil saadud antibakteerikum ning meetod uute bakterivastaste toimeainete identifitseerimiseks

Info

Publication number
EE200300530A
EE200300530A EEP200300530A EEP200300530A EE200300530A EE 200300530 A EE200300530 A EE 200300530A EE P200300530 A EEP200300530 A EE P200300530A EE P200300530 A EEP200300530 A EE P200300530A EE 200300530 A EE200300530 A EE 200300530A
Authority
EE
Estonia
Prior art keywords
antibacterial
agents
preparation
new anti
identifying new
Prior art date
Application number
EEP200300530A
Other languages
English (en)
Inventor
Mayer Frank
Original Assignee
Novologix Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10129870A external-priority patent/DE10129870A1/de
Application filed by Novologix Gmbh filed Critical Novologix Gmbh
Publication of EE200300530A publication Critical patent/EE200300530A/et

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18Testing for antimicrobial activity of a material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EEP200300530A 2001-04-30 2002-04-22 EF-Tu proteiiniga seostuvate ainete kasutamine antibakteriaalse vahendi valmistamiseks, sel viisil saadud antibakteerikum ning meetod uute bakterivastaste toimeainete identifitseerimiseks EE200300530A (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10121145 2001-04-30
DE10129870A DE10129870A1 (de) 2001-04-30 2001-06-21 Antibakterielles Mittel
PCT/EP2002/004410 WO2002087554A2 (de) 2001-04-30 2002-04-22 Ef-tu-bindende substanzen als ntibakterielles mittel

Publications (1)

Publication Number Publication Date
EE200300530A true EE200300530A (et) 2004-04-15

Family

ID=26009202

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300530A EE200300530A (et) 2001-04-30 2002-04-22 EF-Tu proteiiniga seostuvate ainete kasutamine antibakteriaalse vahendi valmistamiseks, sel viisil saadud antibakteerikum ning meetod uute bakterivastaste toimeainete identifitseerimiseks

Country Status (17)

Country Link
EP (1) EP1397157A2 (et)
JP (1) JP2004534016A (et)
CN (1) CN1298739C (et)
AU (1) AU2002302555B2 (et)
BG (1) BG108399A (et)
BR (1) BR0209282A (et)
CA (1) CA2445995A1 (et)
CZ (1) CZ20033271A3 (et)
EE (1) EE200300530A (et)
HU (1) HUP0401586A3 (et)
IL (1) IL158627A0 (et)
MX (1) MXPA03009954A (et)
NZ (1) NZ529662A (et)
PL (1) PL366836A1 (et)
RU (1) RU2003134636A (et)
SK (1) SK14792003A3 (et)
WO (1) WO2002087554A2 (et)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10229645A1 (de) * 2002-07-02 2004-05-19 Kuchenreuther, Ulrich, Dr. Zellaufschluss von Bakterien
HRP20171755T1 (hr) 2009-07-31 2017-12-29 Grünenthal GmbH Postupak kristalizacije i biološka raspoloživost
US9169279B2 (en) 2009-07-31 2015-10-27 Thar Pharmaceuticals, Inc. Crystallization method and bioavailability
US20160016982A1 (en) 2009-07-31 2016-01-21 Thar Pharmaceuticals, Inc. Crystallization method and bioavailability
WO2012071517A2 (en) 2010-11-24 2012-05-31 Thar Pharmaceuticals, Inc. Novel crystalline forms
CN105218668B (zh) * 2015-10-30 2020-03-24 山东农业大学 马耳他型布氏杆菌的EF-Tu蛋白单克隆抗体MAb及其制备方法与应用
US10195218B2 (en) 2016-05-31 2019-02-05 Grunenthal Gmbh Crystallization method and bioavailability

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0466251A1 (en) * 1990-07-10 1992-01-15 Gist-Brocades N.V. Elfamycin-resistant mutants
JP4634604B2 (ja) * 1998-01-23 2011-02-16 アクゾ・ノベル・エヌ・ベー バクテリアの生存率に関するマーカーとしてのEF−TumRNA
US6451556B1 (en) * 1998-12-21 2002-09-17 Smithkline Beecham Corporation EF-Tu

Also Published As

Publication number Publication date
HUP0401586A3 (en) 2005-06-28
WO2002087554A2 (de) 2002-11-07
CA2445995A1 (en) 2002-11-07
WO2002087554B1 (de) 2005-01-27
SK14792003A3 (sk) 2004-07-07
JP2004534016A (ja) 2004-11-11
AU2002302555B2 (en) 2007-08-23
EP1397157A2 (de) 2004-03-17
HUP0401586A2 (hu) 2004-11-29
CZ20033271A3 (en) 2004-06-16
MXPA03009954A (es) 2005-07-25
BR0209282A (pt) 2004-07-27
RU2003134636A (ru) 2005-04-20
BG108399A (bg) 2004-08-31
NZ529662A (en) 2006-08-31
CN1298739C (zh) 2007-02-07
WO2002087554A3 (de) 2003-01-30
IL158627A0 (en) 2004-05-12
CN1518455A (zh) 2004-08-04
PL366836A1 (en) 2005-02-07

Similar Documents

Publication Publication Date Title
EE200200470A (et) Uued ühendid, meetod nende valmistamiseks ning nende kasutamine
DE50110649D1 (de) Zubereitung für restenoseprophylaxe
IS2940B (is) Mótefni gegn CD40
CY2007029I2 (el) Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων
EE200300544A (et) 4-anilinokinoliin-3-karboksamiidid, nende kasutamine ning valmistamine
NO20041907L (no) Angiopoietin-2 spesifikke bindinsmidler
AR028110A1 (es) Nuevo proceso
ITRM20020186A1 (it) Interruttore elettromagnetico per avviatore.
NO20042000D0 (no) Fremgangsmate for flerbrukerinnhold
FI20012426L (fi) Komposiitti-nonwoven, sen käyttö ja menetelmä sen valmistamiseksi
GB2374011C (en) Anti-microbial composition
DE60234410D1 (de) Fehlerschätzendes verfahren
BR0318172B1 (pt) "dispositivo de combinaÇço de impedÂncia, e, mÉtodo para fabricar o mesmo"
EE200300530A (et) EF-Tu proteiiniga seostuvate ainete kasutamine antibakteriaalse vahendi valmistamiseks, sel viisil saadud antibakteerikum ning meetod uute bakterivastaste toimeainete identifitseerimiseks
EE200200697A (et) Uued ühendid, meetod nende valmistamiseks ning nende kasutamine
DE60201193D1 (de) Induktives Bauteil
ATE250611T1 (de) Pyranoindole zur glaukombehandlung
DE50209602D1 (de) Magnetisches bauelement
DE60133014D1 (de) H3 agonisten oder antagonisten
PT1281707E (pt) Processo para a preparacao de isobenzofuranos 5-substituidos
DE60135471D1 (de) H3 agonisten oder antagonisten
ATA80312000A (de) Anschlagschaft für pistolen
AU2003255282A1 (en) Methods for the identification of agents with anti-microbial action
DE50214530D1 (de) Verfahren für den Brieftaubensport
FR2823666B1 (fr) Composition depilatoires hydrosolubles